U.S. Markets open in 5 hrs 41 mins

ImmunoGen, Inc. (IMGN)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.54-0.28 (-4.11%)
At close: 4:00PM EDT
People also watch
SGENIMMUEXELINCYCLDX
Full screen
Previous Close6.82
Open6.90
Bid0.00 x
Ask0.00 x
Day's Range6.50 - 7.00
52 Week Range1.51 - 7.00
Volume3,235,982
Avg. Volume2,530,370
Market Cap584.34M
Beta2.71
PE Ratio (TTM)-3.98
EPS (TTM)-1.64
Earnings DateApr 27, 2017 - May 1, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.73
Trade prices are not sourced from all markets
  • Why ImmunoGen, Inc. Jumped Higher on Monday
    Motley Foolyesterday

    Why ImmunoGen, Inc. Jumped Higher on Monday

    Positive early-stage data sends the biotech's shares up.

  • Capital Cubeyesterday

    ETFs with exposure to ImmunoGen, Inc. : June 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ImmunoGen, Inc. Here are 5 ETFs with the largest exposure to IMGN-US. Comparing the performance and risk of ImmunoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire2 days ago

    ImmunoGen Presents Data from Phase I Study of IMGN779 in Acute Myeloid Leukemia

    ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, presented data from the ongoing Phase 1 study evaluating single agent IMGN779 in patients with relapsed or refractory adult acute myeloid leukemia whose tumors express CD33.